MedPath

A Observational Study to Compare Effectiveness and Safety of the Surgeries in Patients With Esophageal Cancer

Completed
Conditions
Esophageal Cancer
Registration Number
NCT03428074
Lead Sponsor
Chinese PLA General Hospital
Brief Summary

The study was designed to compare effectiveness and safety of the surgeries of Ivor-Lewis and Mckeown in patients with esophageal cancer

Detailed Description

The trial is a multi-centre real-world non-interventional observational study. The study was designed to compare effectiveness and safety of the minimally invasive surgeries of Ivor-Lewis and Mckeown in the Chinese patients with IA-IIIB esophageal cancer via a retrospectively review method based on the study data on patient demographic/tumor biological characteristics and clinical treatments.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1862
Inclusion Criteria
  • Pathologically diagnosed middle and lower thoracic IA-IIIB esophageal cancer after surgeries;
  • Patients who received minimally invasive radical dissections of Ivor-Lewis and Mckeown;
  • Patients who received tubular gastroesophageal reconstruction;
Exclusion Criteria
  • Patients complicated with arrhythmia, or serious disfunctions of heart, lung, liver, and kidney before surgeries;
  • Patients with second primary tumors;
  • Patients who received abdominal or thoracic surgeries;
  • Patients who received gastrostomy or nesteostomy before surgeries;
  • Patients with suspected cervical lymph metastases (in the subgroup of the patients who received the surgery of Mckeown)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Overall survivals in patients with esophageal cancer who received surgeries2010 - 2017

Overall survivals in patients with esophageal cancer who received surgeries categorised by tumor biological characteristics

Secondary Outcome Measures
NameTimeMethod
Death rates within 30 days after surgeries2010 - 2017

Death rates within 30 days after surgeries categorised by tumor biological characteristics

Trial Locations

Locations (9)

China-Japan Friendship Hospital

🇨🇳

Beijing, Beijing, China

Henan cancer hospital

🇨🇳

Zhengzhou, Henan, China

Tongji Hospital Affiliated to Huazhong Technology Hospital

🇨🇳

Wuhan, Hubei, China

Jiangsu Cancer Hospital

🇨🇳

Nanjing, Jiangsu, China

Xi'an Tangdu Hospital

🇨🇳

Xi'an, Shaanxi, China

Shanghai Chest Hospital

🇨🇳

Shanghai, Shanghai, China

Huaxi Hospital Affiliated to Sichuan University

🇨🇳

Chengdu, Sichuan, China

Tianjin Chest Hospital

🇨🇳

Tianjin, Tianjin, China

First Hospital Affiliated to Medical College, Zhejiang University

🇨🇳

Hangzhou, Zhejiang, China

China-Japan Friendship Hospital
🇨🇳Beijing, Beijing, China

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.